I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 35 studies | 43% ± 21% | |
| CD16-negative, CD56-bright natural killer cell, human | 15 studies | 65% ± 16% | |
| CD8-positive, alpha-beta T cell | 14 studies | 22% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 13 studies | 32% ± 19% | |
| mature NK T cell | 13 studies | 38% ± 17% | |
| gamma-delta T cell | 13 studies | 32% ± 14% | |
| innate lymphoid cell | 6 studies | 56% ± 16% | |
| T cell | 5 studies | 20% ± 4% | |
| effector memory CD8-positive, alpha-beta T cell | 5 studies | 23% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 23% ± 6% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 25% ± 11% | |
| group 3 innate lymphoid cell | 3 studies | 40% ± 17% |
